13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Influenza A(H1N1)pdm09 virus exhibiting enhanced cross-resistance to oseltamivir and peramivir due to a dual H275Y/G147R substitution, Japan, March 2016.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          An influenza A(H1N1)pdm09 virus carrying a G147R substitution in combination with an H275Y substitution in the neuraminidase protein, which confers cross-resistance to oseltamivir and peramivir, was detected from an immunocompromised inpatient in Japan, March 2016. This dual H275Y/G147R mutant virus exhibited enhanced cross-resistance to both drugs compared with the single H275Y mutant virus and reduced susceptibility to zanamivir, although it showed normal inhibition by laninamivir.

          Related collections

          Author and article information

          Journal
          Euro Surveill.
          Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
          European Centre for Disease Control and Prevention (ECDC)
          1560-7917
          1025-496X
          Jun 16 2016
          : 21
          : 24
          Affiliations
          [1 ] Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
          Article
          30258
          10.2807/1560-7917.ES.2016.21.24.30258
          27336226
          d5ff31ca-42d2-4740-ad48-0c179183fb0f
          History

          A(H1N1)pdm09,influenza virus,neuraminidase inhibitor,oseltamivir-resistant influenza virus,peramivir-resistant influenza virus

          Comments

          Comment on this article